Stock Market & Financial News
Novo Nordisk: The Falling Knife That Keeps Giving
Novo Nordisk remains a buy despite share price weakness, as strong earnings and robust market share in diabetes and obesity care drive growth. The company's pipeline is rich, with late-stage R&D in obesity, cardiovascular, and rare diseases, including promising drugs like oral semaglutide and Mim8. Shareholder returns are supported by strong free cash flow, double-digit profit growth, and disciplined capital expenditures for future expansion.
Amazon Begins Adding Perishable Groceries to Same-Day Delivery in US
Amazon has begun adding perishable groceries to its Same-Day Delivery service in the United States.
Vireo Growth Inc. (VREOF) Q2 2025 Earnings Call Transcript
Vireo Growth Inc. (OTCQX:VREOF) Q2 2025 Earnings Call August 13, 2025 8:30 AM ET Company Participants J. Tyson Macdonald - Chief Financial Officer John Michael Mazarakis - CEO & Co-Executive Chairman Conference Call Participants Pablo Ernesto Zuanic - Zuanic & Associates Sung-Chul Kim - Zacks Small-Cap Research Operator Good morning, and welcome to the Vireo Growth Inc.'s Second Quarter 2025 Results Call.
Halliburton Elevates ESP Optimization With SK Well Pages
HAL's next-gen Summit Knowledge digital ecosystem boosts ESP performance with real-time insights, predictive tools and enhanced control.
NextDecade's Rio Grande LNG Project Secures Major Funding Boost
NEXT secures $1.8B from TotalEnergies and GIP to advance the Train 4 expansion at its Rio Grande LNG facility in Texas.
Will PPL's Infrastructure Upgrades Boost Its Reliability & Earnings?
PPL is investing heavily in transmission and distribution upgrades to improve service reliability.
Annaly Shares Gains 10.3% in 1H25: Buy, Hold, or Take Profits?
Does NLY's high dividend yield, diversified mortgage portfolio and rising net interest income keep it attractive despite valuation concerns? Let us find out.
Rigetti Computing's Roadmap Is Strong, But The Stock Prices In The Bull Case
Rigetti Computing, Inc. is making strong technical progress, launching a 36-qubit system and targeting a 100+ qubit machine with high fidelity by year-end. RGTI stock's valuation is extremely high, with current prices assuming rapid revenue growth and margin improvement that are not yet visible in the business. The company remains heavily reliant on government funding, which is unpredictable and subject to political delays, impacting near-term revenue.
When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion
ELV trims 2025 outlook as medical costs climb, but commercial growth and Carelon's momentum aim to steady performance.
Gold price could double in 5-10 years as investors become skeptical of fiat currencies - Thorsten Polleit
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
Intapp Stock Rebounds on Beat-and-Raise
Artificial intelligence (AI) stock Intapp Inc (NASDAQ:INTA) was last seen up 11.1% at $41.02 today, after the company posted better-than-expected fiscal fourth-quarter results and lifted its full-year revenue forecast with help from growing cloud revenue.
KP Tissue Inc. (KPTSF) Q2 2025 Earnings Call Transcript
KP Tissue Inc. (OTCPK:KPTSF) Q2 2025 Earnings Call August 13, 2025 8:30 AM ET Company Participants Dino J. Bianco - Chief Executive Officer Doris Grbic - Corporate Participant Michael Keays - Chief Financial Officer Conference Call Participants Hamir Patel - CIBC Capital Markets, Research Division Sean Steuart - TD Cowen, Research Division Zachary Evershed - National Bank Financial, Inc., Research Division Operator Good morning, and welcome to KP Tissue's Second Quarter 2025 Results Conference Call.
Best Momentum Stocks to Buy for August 13th
ANET, RL and APG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 13, 2025.
Estee Lauder (EL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Estee Lauder (EL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lowe's (LOW) Reports Next Week: Wall Street Expects Earnings Growth
Lowe's (LOW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analog Devices (ADI) Earnings Expected to Grow: Should You Buy?
Analog Devices (ADI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TJX (TJX) Reports Next Week: Wall Street Expects Earnings Growth
TJX (TJX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate ZIM Integrated Shipping Services (ZIM) to Report a Decline in Earnings: What to Look Out for
ZIM (ZIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Target (TGT) Q2 Earnings Expected to Decline
Target (TGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Canadian Marijuana Stocks If Federal Reform Passes In The USA
Marijuana stocks have begun to gain traction in trading, exhibiting moderate consistency. But why did this occur, and what is happening to bring such momentum to the sector? Once again, the backing and favorable side of passing federal reform for cannabis is being discussed by top politicians. In recent talks, President Donald Trump voiced his stance on cannabis and how it should be legalized under the right conditions.
Cava shares drop on same-store sales miss for Q2
Cava (NYSE:CAVA) has reported its second quarter earnings, with investors reacting negatively to a miss on same-store sales growth and revenue for the period. The Mediterranean fast-casual restaurant chain posted same-store sales growth of 2.1%, far below estimates of 6.3%.
Ekso Bionics (EKSO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Wall Street Analysts Believe Adeia (ADEA) Could Rally 33.72%: Here's is How to Trade
The consensus price target hints at a 33.7% upside potential for Adeia (ADEA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here's Why Aris Mining Corporation (ARMN) Is a Great 'Buy the Bottom' Stock Now
After losing some value lately, a hammer chart pattern has been formed for Aris Mining Corporation (ARMN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 102.3% in Alvotech (ALVO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts See a 32.34% Upside in ARKO (ARKO): Can the Stock Really Move This High?
The mean of analysts' price targets for ARKO (ARKO) points to a 32.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Janus Henderson Group plc (JHG) Now Trades Above Golden Cross: Time to Buy?
After reaching an important support level, Janus Henderson Group plc (JHG) could be a good stock pick from a technical perspective. JHG recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Wall Street Analysts Think ExlService Holdings (EXLS) Could Surge 28.61%: Read This Before Placing a Bet
The mean of analysts' price targets for ExlService Holdings (EXLS) points to a 28.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade
The mean of analysts' price targets for KALA BIO (KALA) points to a 74.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
How Much Upside is Left in Potbelly (PBPB)? Wall Street Analysts Think 34.86%
The average of price targets set by Wall Street analysts indicates a potential upside of 34.9% in Potbelly (PBPB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
